Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tff Pharmaceuticals, Inc. (TFFP)  
$0.32 0.00 (0.00%) as of 4:30 Mon 12/18


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 18,450,000
Market Cap: 5.90(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.22 - $0.71
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing technology platform. Co. has two product candidates under development, TFF Voriconazole Inhalation Powder and TFF Tacrolimus Inhalation Powder. Co. is engaged in the joint development of an inhaled SARS-CoV2 Monoclonal Antibody in collaboration with Augmenta Bioworks, Inc. and a dry powder formulation of niclosamide in collaboration agreement with UNION therapeutics A/S. Co. is also engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through topical, ocular and nasal applications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 820,000 1,243,360
Total Buy Value $0 $0 $205,000 $1,157,770
Total People Bought 0 0 6 8
Total Buy Transactions 0 0 6 21
Total Shares Sold 0 0 216,000 256,255
Total Sell Value $0 $0 $94,433 $267,127
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 2 3
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 93
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fletcher Aaron G.l. Director   –       •      –    2022-05-16 4 B $4.86 $413,100 I/I 85,000 85,000 2.1 -6%     
   Fletcher Aaron G.l. Director   –       •      –    2022-04-04 4 B $6.43 $3,504,380 I/I 542,000 542,000 2.1 -13%     
   Coleman Kirk Allen CFO, Secretary and Treasurer   •       –      –    2021-09-16 4 B $7.30 $7,300 D/D 1,000 2,000 2.74 -30%     
   Mattes Glenn R. President and CEO   •       •      –    2021-09-16 4 B $7.10 $71,000 D/D 10,000 20,000 2.81 -30%     
   Fairbairn Malcolm Director   –       •      –    2021-05-19 4 B $8.95 $89,500 I/I 10,000 10,000 2.1 -11%     
   Thurman Randy H Director   –       •      –    2021-05-18 4 B $9.40 $9,870 D/D 1,050 1,050 2.39 -12%     
   Lung Therapeutics, Inc. 10% Owner   –       –       •   2021-03-26 4 S $14.00 $10,010,000 D/D (715,000) 2,235,000 39%     
   Mattes Glenn R. President and CEO   •       •      –    2021-03-15 4 AS $17.04 $852,000 D/D (50,000) 10,000 -47%     
   Mattes Glenn R. President and CEO   •       •      –    2021-03-15 4 OE $2.50 $125,000 D/D 50,000 60,000     -
   Coleman Kirk Allen CFO, Secretary and Treasurer   •       –      –    2021-03-15 4 AS $17.05 $85,250 D/D (5,000) 1,000 -47%     
   Coleman Kirk Allen CFO, Secretary and Treasurer   •       –      –    2021-03-15 4 OE $2.50 $12,500 D/D 5,000 6,000     -
   Rocamboli Stephen Director   –       •      –    2021-03-15 4 S $16.85 $337,101 D/D (20,006) 15,722 47%     
   Rocamboli Stephen Director   –       •      –    2021-03-15 4 OE $2.50 $63,140 D/D 20,006 35,728     -
   Coleman Kirk Allen CFO, Secretary and Treasurer   •       –      –    2021-02-16 4 AS $16.82 $84,100 D/D (5,000) 1,000 -42%     
   Coleman Kirk Allen CFO, Secretary and Treasurer   •       –      –    2021-02-16 4 OE $2.50 $12,500 D/D 5,000 6,000     -
   Mattes Glenn R. President and CEO   •       •      –    2021-02-16 4 AS $16.82 $672,800 D/D (40,000) 10,000 -42%     
   Mattes Glenn R. President and CEO   •       •      –    2021-02-16 4 OE $2.50 $100,000 D/D 40,000 50,000     -
   Mills Robert S Director   –       •      –    2021-02-10 4 AS $20.16 $14,112 D/D (700) 15,980 -47%     
   Mills Robert S Director   –       •      –    2021-02-10 4 OE $2.50 $1,750 D/D 700 16,680     -
   Mills Robert S Director   –       •      –    2021-01-20 4 AS $20.20 $254,520 D/D (12,600) 15,980 -45%     
   Mills Robert S Director   –       •      –    2021-01-20 4 OE $2.50 $31,500 D/D 12,600 28,580     -
   Mills Robert S Director   –       •      –    2021-01-19 4 AS $19.56 $1,077,756 D/D (55,100) 15,980 -45%     
   Mills Robert S Director   –       •      –    2021-01-19 4 OE $2.50 $137,750 D/D 55,100 71,080     -
   Mattes Glenn R. President and CEO   •       •      –    2021-01-15 4 AS $17.51 $700,400 D/D (40,000) 10,000 -39%     
   Mattes Glenn R. President and CEO   •       •      –    2021-01-15 4 OE $2.50 $100,000 D/D 40,000 50,000     -
  93 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us